| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |